lilly's patient centric engagement overview
DESCRIPTION
Tom Krohn, Business Lead for the Lilly Clinical Open Innovation Team, gave this presentation at the Patients at the Center of Clinical Research Workshop on Nov. 14, 2013. In it, he discusses ways in which patients can become collaborators in drug developmentTRANSCRIPT
Company Confidential
Copyright © 2013 Eli Lilly and Company
Patient-at-the-Centerof Clinical Trials Workshop
Lilly’s Patient Centric Engagement Overview
14 November 2013
Tom Krohn
What if patients…
• were viewed as collaborators in drug development, not sources of data?
• considered of clinical studies as part of their healthcare treatment options?
• could bring their own data and in real-time determine if they were a match for study eligibility?
• could explore what it was like to be in a study, BEFORE they visited the site?
• received study information in a form that was easy to understand – in THEIR context?
• were viewed as the real heroes of clinical research?
Today’s environment
Patients• Have choice• Are becoming empowered• Are knowledgeable about their disease• Have unmet needs• Often view clinical trials as last resort• Are willing to engage in research, but often do know how
Sponsors (Lilly)• Is committed to innovation• Is targeting unmet needs and therapeutic areas with innovation• Thinks, processes and communicates through a scientific perspective• Primarily reaches patients through investigator sites
Lilly’s Patient-Centric Engagement Strategy
• Voice of patient in development• Patient-centric communication• Enabling marketplace for trial matching• Targeted/Tailored Therapeutics• Patient simulation of study for deep understanding• Patient Experience – before, during and after study
1
Patient-CentricDesign
PatientVoice
2
Patient-Centric Communication & Design Input
Study Representation
Informed ConsentDocumentCt.Gov
Study Design
Open
Platform
Patients
Finding a trial for me
OPENAPI
?
Enabling marketplace for trial matching
Open
Platform
Patients
api.lillycoi.com
Daily Updates
Open Web
RESTAPI
Patient Study“Target Profiles”
Study Sponsors
Patient & Communities
Personal ElectronicMedical Records
MatchProcess
Consentto
Match
April 2014 POC
Targeted/Tailored Therapeutics
Personalized
Medicinegenome
phenotypebiomarkers
quantified self
Lilly’s Patient-Centric Engagement Strategy
• Voice of patient in development• Patient-centric communication• Enabling marketplace for trial matching• Targeted/Tailored Therapeutics• Patient simulation of study for deep understanding• Patient Experience – before, during and after study
Patient Experience
Informed Consent Study mobile app
Streamlined visits Continuity of care
Lilly’s Patient-Centric Engagement Strategy
• Voice of patient in development• Patient-centric communication• Enabling marketplace for trial matching• Targeted/Tailored Therapeutics• Patient simulation of study for deep understanding• Patient Experience – before, during and after study
Breakout Group Themes
• Understanding clinical trials (pre-trial)• Joining a clinical trial (consent)• Support while in a CT• CT Integration into patient lifestyle
• Other?